{"disease":{"id":"unresectable-or-metastatic-advanced-solid-tumors","name":"unresectable or metastatic advanced solid tumors"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03611868","title":"A Study of APG-115 in as a Monotherapy or Combination With Pembrolizumab in Patients With Metastatic Melanomas or Advanced Solid Tumors","phase":"PHASE1, PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":230,"lead_sponsor_name":"Ascentage Pharma Group Inc.","has_results":false},{"nct_id":"NCT06026605","title":"A Dose Escalation and Dose Expansion Trial of WTX212A in the Treatment of Patients with Advanced Malignant Tumors","phase":"EARLY_PHASE1","overall_status":"RECRUITING","enrollment_count":44,"lead_sponsor_name":"Zhejiang University","has_results":false}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}